Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetes, diabetology, emollients/protectives, fever, gastroenterology, haematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, regenerative, respiratory, rheumatology, and urology. The company also exports its products to Europe, Africa, the Americas, rest of Asia, the Commonwealth of Independent States, and Australasia. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Key Metrics
as of Sep 2026
Market Cap 49,883 Cr
P/E 36.30
Div Yield 0.31 %
Book Value βΉ318.00
52w High βΉ2,002.00
52w Low βΉ1,252.00
Face Value βΉ1.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
2,788.00
2,388.00
2,392.00
2,556.00
2,309.00
2,247.00
2,245.00
2,355.00
2,093.00
2,033.00
2,053.00
2,034.00
1,585.00
Expenses
2,119.00
1,905.00
1,859.00
2,012.00
1,892.00
1,818.00
1,782.00
1,913.00
1,700.00
1,711.00
1,722.00
1,673.00
1,278.00
Operating Profit
670.00
484.00
533.00
545.00
416.00
429.00
463.00
441.00
393.00
322.00
331.00
361.00
308.00
OPM %
24.00
20.00
22.00
21.00
18.00
19.00
21.00
19.00
19.00
16.00
16.00
18.00
19.00
Other Income
25.00
48.00
38.00
-30.00
33.00
-179.00
20.00
26.00
21.00
-118.00
91.00
-1.00
45.00
Depreciation
111.00
107.00
108.00
103.00
100.00
100.00
98.00
100.00
99.00
98.00
100.00
90.00
69.00
Interest
12.00
20.00
18.00
20.00
19.00
22.00
17.00
23.00
24.00
29.00
33.00
44.00
31.00
Profit before tax
572.00
404.00
446.00
392.00
331.00
128.00
368.00
345.00
290.00
77.00
289.00
225.00
252.00
Tax %
26.00
24.00
18.00
28.00
29.00
49.00
25.00
29.00
31.00
96.00
23.00
39.00
34.00
Net Profit
424.00
307.00
364.00
281.00
233.00
64.00
276.00
246.00
199.00
1.00
221.00
136.00
164.00
EPS in Rs
15.84
11.79
12.86
11.14
9.19
2.67
9.78
9.05
7.58
2.35
7.09
5.72
6.42
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
9,599.00 8,897.00 7,662.00 6,204.00 5,797.00 5,395.00 4,619.00 3,746.00 3,258.00 3,156.00 2,867.00 3,144.00
Expenses
7,609.00 7,166.00 6,338.00 5,272.00 4,472.00 3,843.00 3,715.00 3,051.00 2,803.00 2,705.00 2,573.00 2,604.00
Operating Profit
1,990.00 1,731.00 1,324.00 932.00 1,325.00 1,552.00 904.00 695.00 455.00 451.00 294.00 541.00
OPM %
21.00 19.00 17.00 15.00 23.00 29.00 20.00 19.00 14.00 14.00 10.00 17.00
Other Income
80.00 -114.00 17.00 123.00 54.00 59.00 65.00 56.00 41.00 11.00 21.00 32.00
Interest
79.00 88.00 141.00 48.00 11.00 12.00 20.00 22.00 28.00 27.00 35.00 32.00
Depreciation
418.00 398.00 357.00 262.00 232.00 209.00 210.00 182.00 178.00 173.00 163.00 180.00
Profit before tax
1,573.00 1,131.00 843.00 745.00 1,136.00 1,389.00 739.00 546.00 291.00 262.00 117.00 361.00
Tax %
24.00 30.00 37.00 34.00 20.00 17.00 18.00 19.00 18.00 26.00 18.00 28.00
Net Profit
1,184.00 785.00 523.00 479.00 890.00 1,141.00 604.00 442.00 239.00 195.00 93.00 254.00
EPS in Rs
44.98 29.08 21.57 18.58 34.85 44.94 23.99 17.60 9.49 7.71 3.69 10.07
Dividend Payout %
0.00 14.00 19.00 22.00 11.00 9.00 10.00 9.00 5.00 6.00 0.00 5.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00
Reserves
8,038.00 6,923.00 6,307.00 5,817.00 5,467.00 4,676.00 3,602.00 3,097.00 2,663.00 2,430.00 2,234.00 2,183.00
Borrowings
809.00 1,363.00 1,438.00 1,481.00 807.00 265.00 501.00 465.00 628.00 716.00 867.00 935.00
Other Liabilities
3,477.00 3,432.00 3,326.00 1,300.00 1,338.00 1,099.00 1,130.00 961.00 799.00 788.00 765.00 669.00
Total Liabilities
12,350.00 11,744.00 11,097.00 8,623.00 7,637.00 6,066.00 5,258.00 4,549.00 4,116.00 3,960.00 3,892.00 3,812.00
Fixed Assets
4,627.00 4,267.00 4,554.00 2,751.00 2,418.00 2,072.00 2,059.00 1,940.00 1,953.00 1,983.00 2,014.00 1,800.00
CWIP
773.00 622.00 343.00 140.00 306.00 235.00 133.00 66.00 73.00 95.00 129.00 267.00
Investments
844.00 980.00 862.00 626.00 989.00 505.00 310.00 120.00 87.00 136.00 26.00 16.00
Other Assets
6,106.00 5,875.00 5,339.00 5,105.00 3,924.00 3,254.00 2,756.00 2,422.00 2,003.00 1,746.00 1,723.00 1,729.00
Total Assets
12,350.00 11,744.00 11,097.00 8,623.00 7,637.00 6,066.00 5,258.00 4,549.00 4,116.00 3,960.00 3,892.00 3,812.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
1,142.00 1,321.00 945.00 806.00 856.00 1,090.00 570.00 501.00 341.00 282.00 709.00 468.00
Cash from Investing Activity
-247.00 -870.00 -1,215.00 -725.00 -851.00 -521.00 -509.00 -165.00 -135.00 -149.00 -218.00 -689.00
Cash from Financing Activity
-754.00 -283.00 -553.00 507.00 427.00 -306.00 -137.00 -183.00 -130.00 -159.00 -462.00 251.00
Net Cash Flow
142.00 169.00 -823.00 588.00 432.00 264.00 -76.00 153.00 75.00 -26.00 29.00 29.00
Free Cash Flow
486.00 551.00 543.00 347.00 380.00 731.00 277.00 322.00 206.00 147.00 463.00 -207.00
CFO/OP %
78.00 97.00 94.00 110.00 80.00 86.00 80.00 88.00 88.00 74.00 251.00 100.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
77.00 77.00 80.00 58.00 57.00 55.00 71.00 66.00 67.00 58.00 57.00 41.00
Inventory Days
353.00 336.00 350.00 276.00 337.00 337.00 294.00 316.00 286.00 290.00 289.00 293.00
Days Payable
122.00 111.00 110.00 83.00 101.00 140.00 135.00 154.00 137.00 130.00 145.00 97.00
Cash Conversion Cycle
308.00 302.00 321.00 251.00 293.00 251.00 229.00 228.00 216.00 218.00 200.00 237.00
Working Capital Days
109.00 101.00 111.00 71.00 102.00 103.00 88.00 88.00 80.00 74.00 61.00 68.00
ROCE %
17.00 15.00 13.00 11.00 20.00 31.00 19.00 16.00 10.00 9.00 5.00 14.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
44.72
44.72
44.72
44.72
44.72
44.72
44.72
46.30
46.30
46.30
46.29
46.29
FIIs
10.72
10.63
10.62
10.42
10.67
10.75
11.06
10.83
10.85
10.51
10.27
9.86
DIIs
37.04
37.13
36.99
36.45
35.88
35.73
35.36
33.90
33.46
34.05
34.19
34.72
Public
7.19
7.21
7.33
8.09
8.41
8.45
8.53
8.64
9.07
8.82
8.93
8.80
No. of Shareholders
82,060
82,184
77,673
82,870
85,582
88,306
90,189
82,975
84,753
81,165
82,809
95,930
Corporate Actions
50 records
Back to all stocks